Schwartz ME - Search Results

1

Accuracy and significance of computed tomographic scan assessment of hepatic volume in patients undergoing liver transplantation.

Schiano TD, Bodian C, Schwartz ME, Glajchen N, Min AD. Schiano TD, et al. Among authors: schwartz me. Transplantation. 2000 Feb 27;69(4):545-50. doi: 10.1097/00007890-200002270-00014. Transplantation. 2000. PMID: 10708109

2

The splenic artery as the inflow in arterial revascularization of the liver graft in clinical liver transplantation.

Katz E, Fukuzawa K, Schwartz M, Mor E, Miller C. Katz E, et al. Transplantation. 1992 Jun;53(6):1373-4. Transplantation. 1992. PMID: 1376505 No abstract available.

3

Evidence that the systematic analysis of bile cytology permits monitoring of hepatic allograft rejection.

Roberti I, Lieberman KV, Manzarbeitia C, Schwartz M, Reisman L, Miller C. Roberti I, et al. Transplantation. 1992 Sep;54(3):471-4. doi: 10.1097/00007890-199209000-00017. Transplantation. 1992. PMID: 1384182

4

Orthotopic liver transplantation for secondary sclerosing cholangitis associated with hepatic artery embolization.

Manzarbeitia C, Schwartz ME, Berman HL, Miller CM. Manzarbeitia C, et al. Among authors: schwartz me. Transplant Proc. 1992 Apr;24(2):745-7. Transplant Proc. 1992. PMID: 1566504 No abstract available.

5

Accessory right hepatic duct stricture following liver transplantation.

Manzarbeitia C, Schwartz ME, Train JS, Miller CM. Manzarbeitia C, et al. Among authors: schwartz me. Transplantation. 1991 Sep;52(3):556-8. Transplantation. 1991. PMID: 1897031 No abstract available.

6

Initial flush solution for donor liver procurement: lactated Ringers' or UW solution? A randomized, prospective trial.

Schwartz ME, Nishizaki T, Thung SN, Manzarbeitia C, Maharajh A, Gordon R, Miller CM. Schwartz ME, et al. Transplant Proc. 1991 Feb;23(1 Pt 2):1554-6. Transplant Proc. 1991. PMID: 1989287 Clinical Trial. No abstract available.

7

Resistant hepatic allograft rejection successfully treated with cyclophosphamide and plasmapheresis.

Evrard HM, Miller C, Schwartz M, Thung SN, Mayer L. Evrard HM, et al. Transplantation. 1990 Oct;50(4):702-4. doi: 10.1097/00007890-199010000-00033. Transplantation. 1990. PMID: 2219293 No abstract available.

8

FK506 versus cyclosporine as primary immunosuppressive agent for orthotopic liver allograft recipients. Histologic and immunopathologic observations.

Hytiroglou P, Lee R, Sharma K, Theise ND, Schwartz M, Miller C, Thung SN. Hytiroglou P, et al. Transplantation. 1993 Dec;56(6):1389-94. doi: 10.1097/00007890-199312000-00022. Transplantation. 1993. PMID: 7506452 Clinical Trial.

9

Therapy with FK 506 in pediatric liver recipients.

Rosh JR, Schwersenz AH, Schwartz M, Moran V, Leleiko N, LeLeiko VM, Miller CM. Rosh JR, et al. Transplant Proc. 1994 Feb;26(1):152-3. Transplant Proc. 1994. PMID: 7509091 Clinical Trial. No abstract available.

10

Reversal of gastrointestinal toxicity associated with long-term FK506 immunosuppression by conversion to cyclosporine in liver transplant recipients.

Mor E, Schwersenz A, Sheiner PA, Emre S, Schwartz ME, Miller CM. Mor E, et al. Among authors: schwartz me. Transplantation. 1994 Apr 15;57(7):1130-2. Transplantation. 1994. PMID: 7513098 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

473 results

Search Page

Filters